Prostacyclin Drug Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2028

The prostacyclin drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Prostacyclin drugs are used to treat pulmonary arterial hypertension (PAH), a disease in which the arteries that convey deoxygenated blood from the heart to the lungs have excessive blood pressure. PAH prostacyclin analogues are synthetic versions of prostacyclin, a naturally occurring chemical. The major factor driving the growth of the market includes the rising prevalence of pulmonary arterial hypertension globally. According to the National Organization for Rare Disorders, females are 3-5 times more likely than males to be exposed to PAH. Females between the ages of 30 and 60 years are more likely to be affected. In the US, new cases are anticipated to arise in one to two people per million every year. In Europe, the incidence is anticipated to be comparable. There is no recognized ethnic or racial group that has a greater prevalence of PAH patients.

Scope of the Prostacyclin Drug Report

The research study analyzes the Prostacyclin Drug industry from a 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis

o Import and Export Overview

o Volume Analysis

o Current Market Trends and Future Outlook

o Market Opportunistic and Attractive Investment Segment

Prostacyclin Drug Market Segmentation:

By Drug Type

• Epoprostenol
• Treprostinil
• Iloprost
• Others

By Route of Administration

• Tablets
• Injections
• Inhalation

Competitive Landscape- GlaxoSmithKline PLC., Teva Pharmaceuticals Industries Ltd., Actelion Pharmaceuticals US, Inc., United Therapeutics Corp., Sandoz AG, and Dr. Reddy’s Laboratories Ltd, among others.

Geographic Coverage

o North America Market Size and/or Volume

o Latin America Market Size and/or Volume

o Europe Market Size and/or Volume

o Asia-Pacific Market Size and/or Volume

o Rest of the world Market Size and/or Volume

Key questions answered in this report:

• What is the size of the Prostacyclin Drug market and what is its expected growth rate?
• What are the primary driving factors that push the Prostacyclin Drug Market forward?
• What are the Prostacyclin Drug Industry’s top companies?
• What are the different categories that the Prostacyclin Drug Market caters to?
• What will be the fastest-growing segment or region?
• In the value chain, what role do essential players play?
• What is the procedure for getting a free copy of the Prostacyclin Drug Market sample report and company profiles?